share_log

花旗:予药明合联(02268)“买入”评级 目标价41港元

Citigroup: Gives a 'buy' rating to Pharmaron (02268) with a target price of HKD 41.

Zhitong Finance ·  Jul 26 14:17  · Ratings

Citigroup has initiated a 30-day bullish observation on Joinn Laboratories (02268).

According to the research report released by Citigroup, they have initiated a 30-day bullish observation on Joinn Laboratories (02268) with a target price of HKD 41 and a buy rating. Due to the strong demand for the company's projects, it is expected to achieve ideal performance in the first half of the year, with the expected year-on-year profit growth rate of 57%, while the market forecast growth is 48%. In addition, the management also stated that the order trend is good.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment